The news of Morgan Stanley maintaining an Equal-Weight rating on Couchbase and raising the price target from $19 to $20 indicates that the analyst sees potential in the stock but does not expect significant outperformance in the short term. This may not have a strong impact on the stock price in the short term, but it could provide some support for the stock.